Table 1. Cell Apoptosis Evaluation by Flow Cytometry after Treatment with CuS NPsa.
| fibroblasts |
monocytes |
macrophages |
mMSCs |
|||||
|---|---|---|---|---|---|---|---|---|
| control | NPs CuS | control | NPs CuS | control | NPs CuS | control | NPs CuS | |
| necrosis | 1.5% | 1.6% | 0.3% | 0.8% | 1.4% | 3.0% | 1.4% | 0.9% |
| late apoptosis | 4.7% | 4.7% | 6.3% | 17.6% | 5.7% | 9.0% | 14.1% | 17.6% |
| early apoptosis | 5.6% | 7.1% | 9.1% | 10.4% | 9.2% | 16.4% | 11.0% | 10.9% |
| viability | 88.2% | 86.6% | 84.3% | 71.3% | 83.7% | 71.6% | 73.5% | 70.7% |
a
Control samples (not treated cells) were analyzed as background apoptosis level.